Published: Jan. 2023

New technologies for fighting cancer are extending some patients’ lives and hold the vast potential to do the same for many others — in some cases offering cures for diseases that were once considered a death sentence. Immunotherapies rely on biological targets that scientists can use to turn the immune system into a weapon that kills cancer cells or disables the malignant cells’ defenses.

This report is an authoritative guide to these game-changing treatments, informed by STAT’s original reporting and expert analysis. In it, you will:

• Get the latest information about these novel therapies and their successes and failures.
  
• Gain an understanding of the biology of cancer targets and the strategies scientists are using in designing drugs to harness them.
  
• And learn about five cancer targets — LAG-3, TGF-beta, CLDN6, mesothelin, and KRAS — that pharmaceutical and biotech companies are actively pursuing.